ALERT:Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Aims : to present important clinical trials in respiratory medicine; to summarise key findings and discuss with the audience experts conclusions, to bring clinical trial’s abstracts into the clinical context. This session is led by a chair and two expert discussants who will facilitate the discussions and summarise key messages.
Target audience :
Adult pulmonologist/Clinician, Trainee, Clinical researcher, Critical/Intensive care physician, Scientist (basic, translational), General practitioner
Late Breaking Abstract - Phase 2a randomised, double-blind, placebo-controlled, crossover study of a novel P2X3 receptor antagonist S-600918 in patients with refractory chronic cough
A. Niimi(Nagoya, Japan)